Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.

about

Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.

Item

http://www.wikidata.org/entity/Q49347684

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@en

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@nl

type

Item

label

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@en

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@nl

prefLabel

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@en

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@nl

P1476

Antithrombotic therapy in 2017 ...... llation, and valvular disease.

@en

P2093

Deepak L Bhatt

http://www.w3.org/2001/XMLSchema#string

P2860

Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fi

Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

P2888

nrcardio.2017.212

P304

71-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2017.212

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100155474

http://www.w3.org/2001/XMLSchema#string

P698

29297509

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation